mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |